semaglutide for kidney disease AHA 2024: continues to impress in diabetic 💉 The FDA has approved

If you tend to retain fluid in your face, the diuretic effect of spironolactone can lead to a less puffy appearance

The most important intervention to support growth is optimizing nutritional support during GLP-1 treatment, he says

Human Evidence: Dementia/Alzheimers Outcomes Observational & Emulated-Trial data (signal of benefit) Large real-world datasets now associate GLP-1 use with lower dementia risk compared with other antidiabetic drugs

FDA safety communications regarding compounded semaglutide: The FDA has issued specific warnings about compounded GLP-1 products that every potential patient should be aware of